Referenzen
Zu meinen Referenzen zählen unter anderem zahlreiche Unternehmen aus der pharmazeutisch-technischen Industrie, wie zum Beispiel:
- Merz Pharmaceuticals GmbH - Frankfurt/Main
- Allergopharma Joachim Ganzer KG - Reinbek bei Hamburg
- Scope International Life Sciences Mannheim AG
- Dr. August Wolff GmbH & Co. KG Arzneimittel - Bielefeld
- InfectoPharm GmbH - Heppenheim
Publikationen
- Longin E, Dimitriadis C, Shazi S, Gerstner T, Lenz T, König St: Automatic nervous system functions in infants and adolescents: Impact of autonomic tests on heart rate variability. Pediatr Cardiol. In print
- Schwarz M, Rose S, Becker K, Lenz T, Jani L: Effects of surface roughness porosity and a resorbable calcium phosphate coating on osseointegration of titanium in a minipig model. J. of Biomechanical Materials Research: Part A In print
- Longin E, Reinhard J, von Buch C, Gerstner T, Lenz T, König St: Autonomic Function in Children and Adolescents with Neurocardiogenic Syncope. Pediatr Cardiol. 2008 Feb 14
- Fölster-Holst R, Müller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Rüden U, Schrezenmeir J, Christophers E, Weichenthal M: Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Pediatric Dermatology (2006)
- Schöfer H, van Ophoven A, Henke U, Lenz T, Eul A: Randomized, comparative trial on sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts. Eur J Dermotol 16(6): 1-7 (2006))
- Longin E, Gerstner Th, Schaible T, Lenz T, König St: Maturation of the autonomic system: differences in heart rate variability in premature vs. term infants. J. Perinat. Med. (2006)
- Longin E, Schaible Th, Demirakca S, Lenz T, König St: Heart rate variability during extracorporeal membrane oxygenation and recovery in severe neonatal disease. Early Human Development 82: 135-142 (2006)
- Longin E, Schaible Th, Lenz T, König St: Short term heart rate variability in healthy neonates: Normative data and physiological observations. Early Human Development 81: 663-671 (2005)
- Michel MS, Ptashnyk T, Musial A, Braun P, Köhrmann KU, Lenz ST, Alken P: Objective and subjective symptom change in patients with Peyronie’s disease after management with shock wave therapy. J Endourol. 17(1):41-44 (2003)
- König StA, Knolle J, Friedewald St, Koelfen W, Longin E, Lenz T, Hannak D: Effects of valproic Carbamazepine and Phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia 44(5): 708-711 (2003)
- Brand H, Lenz T: Information-Systems for the Public-Health Services What do they need. Toxicological and Environmental Chemistry 40(1-4): 301-304 (1993)